{"task_id": "dd540edb6ca7fc1d", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 347/464)", "text": "giving HCO3 is not necessary\n338\nDiabetes Mellitus\n\n--- Page 360 ---\nACUTE MANAGEMENT OF DIABETIC KETOACIDOSIS\n(CONT\u2019D)\n\u0002\nPHOSPHATE\nno indication for replacement in the\nacute setting unless there is severe cardiac or\nrespiratory depression\n\u0002\nLABS\nobtain hourly ABGs, lytes, bicarb, anion gap,\nACUTE MANAGEMENT OF DIABETIC KETOACIDOSIS\n(CONT\u2019D)\nglucose, serum osmolality, ketones. Cerebral\nedema is a concern (particularly in children) if\nosmolality/sodium parameters are corrected too\nquickly\nTREAT PRECIPITATING FACTOR(S)\nHour 2\nHour 1\nHours 3\u22124\nHours 5\u22128\nHours 8\u221224\nHydration\nIV #1\nNS or \u00bd NS\n\u00b1 potassium \nreplacement\n1 l NS (i.e. 15\u221220 mL/kg/h)\nUse \u00bdNS if corrected Na \n>145 mmol/L (for every \n10 mmol/L[182 mg/dL] \u2191 in \nblood glucose, correct Na \nby \u2191 3 mmol/L)\n500 mL/h NS\n500 mL/h NS\n250 mL/h NS\nWhen glucose <15 mmol/L \n[<270 mg/dL], change IV to D5\u00bd \nNS @ 250 mL/h (if corrected \nsodium is low, use D5NS). If \nglucose <15 mM [<270 mg/dL], but \nAG still \u2191, run D10W at 80 mL/h \nso that IV insulin can be \u2191\n125\u2212250 mL/h D5\u00bd NS\nInsulin\nIV #2\nMix 25 units \nreg insulin in \n250 ml D5W\n(1 unit =10 mL)\nBolus 0.1 units/kg regular IV \ninsulin (e.g. 7 units for 70 kg)\nThen 0.1 un ts/kg/h initia ly \nfollowing bolus (e.g. 5\u221210 \nunits/h)\nHold for 2 h if hypotensive or \nK <3.5 mEq/L\nTarget glucose 10\u2212\n15 mmol/L\nContinue IV insulin\nExpect a glucose fall of \n5 mmol/h [90 mg/dL/h]\nTitrate insulin against AG.\nDouble dose f poor \nresponse\nA drop in glucose >3\u2212\n5 mmol/h [>54\u2212\n90 mg/dL/h] increases risk \nof cerebral edema (mostly \nin children\nWhen glucose <15 mM [<270mg/d], decrease IV to 2\u22124 units/h, \nbut continue IV until ketosis cleared; use following scale:\nGlucose\nmM            mg/dL\nInsulin drip\n<5\n<90\nStop and recheck in 1 h\n5.1\u221210\n91\u2212180\nDecrease by 1 un ts/h\n10.1\u221215\n181\u2212270\nNo change\n15.1\u221220\n271\u2212360\nIncrease by 1 units/h\n20.1\u221224\n361\u2212437\nIncrease by 2 units/h\n>24\n>438\nIncrease by 3 units/h and call MD\nIf glucose drops by more than 5 mM [90 mg/dL] in 2 h, decrease \ninsu in to 0.5 units/h and call MD\nAfter ketoacidosis has \ncleared, switch to SC \ninsu in and thenstop IV \ninsu in\nUsua ly keep IV insulin for \nfirst day; do not stop \novernight\nPotassium \nreplacement\n(when voiding)\nSerum potassium\n<3 mEq/L, give\n3\u22124 mEq/L, give\n4\u22125 mEq/L, give\n5\u22126 mEq/L, give\nPotassium replacement\n40 mEq/h\n30 mEq/h\n20 mEq/h\n10 mEq/h\nLaboratory\nBaseline: glucose, \u03b2-OH-\nbutyrate, ABG, urinalysis, \nCBCD, electrolytes, Cr, \nPO4, Mg, \u00b1 lipase, CXR, \ncultures, troponin, ECG\nGlucose (C/S), lytes \n(VBG)\nABGs if pH <7.0\nGlucose (C/S), lytes (VBG)\nABGs if pH <7.0\nGlucose (C/S) hourly, lytes \n(VBG), PO4\nGlucose (C/S) q1\u22122h\nlytes q4\u22128h\nAlkaline \nreplacement\nRarely indicated unless severe acidosis (pH <6.9) with incipient circulatory collapse\nDose 50\u2212100 mEq, NaHCO3 in \u00bdNS over 30\u221260 mins\nExtra potassium may be needed w th bicarbonate therapy\nPhosphate \nreplacement\nConsider if serum phosphorus <0.65 mmol/L [<2.0 mg/dL] and give if serum phosphorus <0.35 mmol/L [<1.1 mg/dL]\n2.5\u22128 mmol/l/h [8\u221225 mg/dL] (1 mmoL of phosphate = 31 mg of elemental phosphorus)\n(e.g. 10 mL of KPO4 in 1 l NaCl over 6 h (30 mM PO4, 44 mEq K)\nGeneral \nmeasures\nMake flow sheet (ABG\u2019s, glucose, lytes, bicarb, \nAG, \u00b1O2, urine output), q1h v tals\nNG tube if unconscious, ant biotics if infection, \nAbbreviations: ABG=arterial blood gas, AG=anion gap, CBCD=CBC and differential, C/S=chemstrips, NS=normal saline, VBG=venous blood gas\ncardiac monitor when acidotic, give fluid (6\u22128 L\ndeficit)\nFoley to urometer f no urine for 4 h\nNOTE  this table should not replace individualized care and sound clinical judgment\nSPECIFIC ENTITIES\nNON KETOTIC HYPEROSMOLAR HYPERGLYCEMIA\n\u0002\nPATHOPHYSIOLOGY\noccurs in patients with type 2\ndiabetes\n\u0002\nCLINICAL\nFEATURES\ncharacterized by profound\ndehydration, increased osmolar state, severe ele\nvation in blood glucose along with hypernatremia.\nKetones may be mildly elevated or absent.\nPatients often present in a comatose state or\nhave a decreased level of conscience\n\u0002\nTREATMENTS\nfluid resuscitation along with an\ninsulin drip. Need to correct Na for elevated\nglucose (add 3 mEq/L to the serum Na for every\nrise of 10 mmol/L [182 mg/dL] of glucose above\n10 mmol/L [182 mg/dL]. To minimize risk of\ncerebral edema, serum Na should ideally drop\nby no more than 8 mEq/L/day, serum osmolality\nshould drop by no more than 3 mEq/L/h, and\nglucose should drop by no more than 3 mEq/l/h.\nLower insulin requirement compared to DKA.\nMortality 10 20%\nLONG TERM MANAGEMENT\nRISK REDUCTION wABCDEFGw\n\u0002 ASA/ACE INHIBITOR\nASA 81 mg PO daily for sec\nondary prevention, controversial for primary pre\nvention. ACE inhibitor or ARB should be started if\nmicroalbuminuria\n\u0002 BLOOD PRESSURE CONTROL\nfirst line therapy: ACE\ninhibitor, ARB, dihydropyridine CCB, or thiazide\nlike diuretics. Aim for <130/80 mmHg\n\u0002 CHOLESTEROL\nCONTROL\nthe\ntargets\nare\nLDL\n<2.0 mmol/L [<77 mg/dL], TGL <1.5 mmol/L\n[<130 mg/dL] and total chol/HDL ratio <4. Con\nsider fibrates (# triglycerides, \" HDL), HMG CoA\nSPECIFIC ENTITIES (CONT\u2019D)\nDiabetes Mellitus\n339", "text_length": 5009, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 347/464)", "type": "chunk", "chunk_index": 346, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.725416", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.726325", "status": "complete", "chunks_added": 3}